NODE-301 part 2 (RAPID)
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
- Stage
- klaar
- Medicine
- Etripamil
- Population
- Ritme
- Phase
- III
- First Patient In
- 30 April 2021
- Last Patient In
- 15 August 2022
- Last Patient Last Visit
- 14 December 2022
National Lead
dr. A.M.W. Alings
Cardioloog
Study Director
dr. R. Pisters
Cardioloog
Office Contact
